All articles tagged with #rklb
SpaceX’s Falcon 9 mission delivering 29 Starlink satellites and booster landing spurred mixed moves in space stocks: RKLB +2.8%, ASTS +3.3%, LUNR −5.2%, SPCE −2.7%. Analysts show varied ratings across the group, with Intuitive Machines (LUNR) seen as the strongest buy and SPCE offering the largest upside. SpaceX remains private, with IPO chatter ongoing; TSLA is suggested as a potential proxy for investors until an IPO materializes.
Rocket Lab's revenue mix is moving toward defense-related programs, with Space Systems delivering a large portion of Q4 revenue and the backlog expanding to $1.85 billion. A delay of the Neutron program to late 2026 adds near-term execution risk, while the stock trades around 52x 2026 sales, reflecting lofty growth expectations as management targets revenue growth from roughly $850 million to about $3.7 billion over the next five years.
Rocket Lab (RKLB) stock slipped after Congress scrapped a plan to return NASA Mars Perseverance rover samples, a project Rocket Lab proposed handling by 2031 under a fixed-price contract; the setback matters less for near-term revenue but RKLB’s high valuation (~45x expected 2027 sales) makes it sensitive to headlines, with analysts still signaling a Moderate Buy and about 15% upside ahead of Artemis II.
Rocket Lab's stock soared 9.5% after successfully launching a mission for the U.S. Space Force ahead of schedule, demonstrating its reliability in national security launches. Despite recent volatility and profit-taking after a 141% year-to-date increase, the company's strong performance and technological achievements suggest potential for continued growth, though the stock remains below its 52-week high.
Rocket Lab (RKLB) has received a street-high price target amid comparisons to SpaceX, indicating strong investor confidence and positive outlook for the company's growth prospects.